Draft guidance on vortioxetine
The National Institute for Health and Care Excellence (NICE) has published draft guidance requesting more information from Lundbeck about its drug vortioxetine (Brintellix) for treating major depressive episodes in adults. A consultation on the draft guidance is available from the NICE website until 1 July 2015.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068720
Recommended from Pharmaceutical Press
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£82.00Buy now
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now